Demonstrated in vivo effect

Follow

Industry

CPC
C12N2760/10071

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2760/00ssRNA Viruses negative-sense

Current Industry

C12N2760/10071Demonstrated in vivo effect

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Method for producing an antitumoral arenavirus as well as arenaviru...
- Patent number 12,129,281
- Issue date Oct 29, 2024
- ABALOS THERAPEUTICS GMBH
- Karl Lang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lassa vaccine
- Patent number 11,976,305
- Issue date May 7, 2024
- Institut Pasteur
- Mathieu Mateo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
METHOD FOR PRODUCING AN ANTITUMORAL ARENAVIRUS AS WELL AS ARENAVIRU...
- Publication number 20220033445
- Publication date Feb 3, 2022
- ABALOS THERAPEUTICS GMBH
- Karl LANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LASSA VACCINE
- Publication number 20200308555
- Publication date Oct 1, 2020
- INSTITUT PASTEUR
- Mathieu MATEO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE